Guinea-Bissau suspends US-funded vaccine trial as African scientists question its motives

The continuing row highlights long-standing tensions over clinical research trials in Africa that are proposed and run by researchers in other countries. African scientists say that the Guinea-Bissau study shows how political pressure, funding interests and fragmented oversight can push local health priorities aside.